What is Mani, Inc.?
engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally.
MNICF · Verdict
Moderate reward · low risk
MNICF stands out on volatility and cash flow, but watch the growth signal.
Based on 88% data coverage
MNICF · Verdict
Top decile vs peers
1% free-cash-flow margin
15% net margin · 10% ROE
Rev +13.6% CAGR · earnings -4.3%
Model-based scoring. For information only — not financial advice.
engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.26B, and a P/E ratio of 30.5x.
The scoring profile indicates limited reward potential at this time, with profitability and momentum offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.